Compare StocksABBV vs BR

AbbVie Inc. (ABBV) vs Broadridge Financial Solutions, (BR): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. BR is undervalued at $154, with an intrinsic value of $21337101183 and a margin of safety of 100%. Of the two, BR has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
BR
Broadridge Financial Solutions,
$153.95

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
BR
  • Broadridge Financial Solutions, has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Broadridge Financial Solutions, scores 91/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 41.8% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
BR

    Key Valuation Metrics

    Learn more →
    ABBV
    BR
    Valuation
    N/A
    Free Cash Flow
    $1.19B
    N/A
    FCF Yield
    N/A
    70.89
    Trailing P/E
    16.48
    15.41
    Forward P/E
    14.78
    Quality & Moat
    27.60%
    ROIC
    17.10%
    N/A
    ROE
    42.31%
    72.79%
    Gross Margin
    31.31%
    0.41
    PEG Ratio
    1.06
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    1.10
    N/A
    Interest Coverage
    N/A
    2.06
    Net Debt / EBITDA
    1.76
    2.76%
    Dividend Yield
    2.53%
    ABBV: 4Ties: 2BR: 2
    ABBVBR

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    BR

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    BR
    $0.00
    created per $1 retained over 3 years
    Value Destroyer
    Σ Retained
    $1.07B
    Δ Market Cap
    +$89.04
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    40.7% Overvalued
    Price is 40.7% above estimated fair value
    Current Price: $250.94
    Fair Value: $178.31
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    BR
    100.0% Margin of Safety
    Price is 100.0% below estimated fair value
    Current Price: $153.95
    Fair Value: $21337101183.30
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    Requires positive FCF to compute implied growth rate.

    BR

    What growth rate is the market pricing in at $154?

    -21.0%
    Market-Implied Owner Earnings Growth
    Standard FCF implies -23.3%

    The market implies -21.0% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding -23.3%, reflecting heavy growth investment expected to generate future returns.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    BR
    91/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    BR
    -2.66
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
    No. of Institutional Holders5,146
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    BR
    Insiders 0.5%Institutions 99.0%Retail & Other 0.6%
    No. of Institutional Holders1,451
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    BR
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $1.03M
    GOKEY TIMOTHY C.
    Chief Executive Officer
    $1.03M
    @ $194.49 · 2026-03-06
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    0
    Sells (3M)
    0
    Sells (12M)
    No open market insider sales found.
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    BR
    1
    Sells (3M)
    8
    Sells (12M)
    Total value (12M): $43.49M
    JARKOWSKI HOPE M.
    Officer
    $304,720
    @ $154.99 · 2026-06-04
    DUELKS ROBERT N
    Director
    $48,728
    @ $192.60 · 2026-02-06
    CAREY THOMAS PATRICK
    Officer
    $2.34M
    @ $229.26 · 2025-12-03
    PERRY CHRISTOPHER JOHN
    President
    $900,384
    @ $226.00 · 2025-11-18
    GOKEY TIMOTHY C.
    Chief Executive Officer
    $1.47M
    @ $258.37 · 2025-08-25
    GOKEY TIMOTHY C.
    Chief Executive Officer
    $1.48M
    @ $260.87 · 2025-08-18
    GOKEY TIMOTHY C.
    Chief Executive Officer
    $35.10M
    @ $260.36 · 2025-08-15
    PERRY CHRISTOPHER JOHN
    President
    $1.85M
    @ $262.72 · 2025-08-12
    DUELKS ROBERT N
    Director
    $122,575
    @ $245.15 · 2025-06-06
    DESCHUTTER DOUGLAS RICHARD
    President
    $1.20M
    @ $245.76 · 2025-06-06
    MARKUS MAURA A
    Director
    $864,408
    @ $243.08 · 2025-06-04
    DESCHUTTER DOUGLAS RICHARD
    Officer
    $1.21M
    @ $239.55 · 2025-05-27
    CARTER PAMELA LYNN
    Director
    $1.17M
    @ $242.23 · 2025-05-20
    JARKOWSKI HOPE M.
    Officer
    $257,615
    @ $240.99 · 2025-05-15
    CAREY THOMAS PATRICK
    Officer
    $855,798
    @ $237.26 · 2025-05-13
    STINGI RICHARD JOHN
    Officer
    $187,848
    @ $234.81 · 2025-05-07
    JARKOWSKI HOPE M.
    Officer
    $251,220
    @ $235.22 · 2025-05-07
    GOKEY TIMOTHY C.
    Chief Executive Officer
    $2.87M
    @ $245.07 · 2025-04-02
    GOKEY TIMOTHY C.
    Chief Executive Officer
    $22.59M
    @ $235.43 · 2025-03-10
    PERRY CHRISTOPHER JOHN
    President
    $5.26M
    @ $235.23 · 2025-03-07
    DUELKS ROBERT N
    Director
    $1.99M
    @ $237.15 · 2025-02-26
    KELLER BRETT A
    Director
    $1.31M
    @ $240.40 · 2025-02-06
    MATLIN LAURA
    General Counsel
    $124,181
    @ $241.60 · 2025-02-04
    CAREY THOMAS PATRICK
    Officer
    $3.62M
    @ $230.32 · 2024-12-03
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😏Greed(61/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    BR
    FearGreed
    😨Fear(38/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
    BR
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (38)
    View ABBV Full AnalysisView BR Full Analysis

    Frequently Asked Questions: ABBV vs BR

    Is AbbVie Inc. or Broadridge Financial Solutions, more undervalued in 2026?

    Based on our discounted cash flow model, BR trades at a 100.0% margin of safety (intrinsic value $21337101183 vs. price $154), compared to ABBV's -40.7% margin of safety (intrinsic $178 vs. $251).

    Which stock has a wider economic moat, AbbVie Inc. or Broadridge Financial Solutions,?

    BR scores 91/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Broadridge Financial Solutions, in financial distress?

    BR's Altman Z-Score of 1.9 places it in the Grey zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, AbbVie Inc. or Broadridge Financial Solutions,?

    ABBV earns 27.6% ROIC versus BR's 17.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, AbbVie Inc.'s or Broadridge Financial Solutions,'s?

    BR's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). BR has raised its dividend for 3 consecutive years.

    ABBV vs BR: Which Is the Better Buy in 2026? | SafetyMargin.io